JP2008543729A5 - - Google Patents

Download PDF

Info

Publication number
JP2008543729A5
JP2008543729A5 JP2007558257A JP2007558257A JP2008543729A5 JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5 JP 2007558257 A JP2007558257 A JP 2007558257A JP 2007558257 A JP2007558257 A JP 2007558257A JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007558257A
Other languages
Japanese (ja)
Other versions
JP2008543729A (en
JP5110697B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2007558257A priority Critical patent/JP5110697B2/en
Priority claimed from JP2007558257A external-priority patent/JP5110697B2/en
Publication of JP2008543729A publication Critical patent/JP2008543729A/en
Publication of JP2008543729A5 publication Critical patent/JP2008543729A5/ja
Application granted granted Critical
Publication of JP5110697B2 publication Critical patent/JP5110697B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

Figure 2008543729
Figure 2008543729

JP2007558257A 2005-06-27 2006-06-26 Solid preparation Active JP5110697B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007558257A JP5110697B2 (en) 2005-06-27 2006-06-26 Solid preparation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005187214 2005-06-27
JP2005187214 2005-06-27
JP2007558257A JP5110697B2 (en) 2005-06-27 2006-06-26 Solid preparation
PCT/JP2006/313176 WO2007001067A2 (en) 2005-06-27 2006-06-26 Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012177601A Division JP5456857B2 (en) 2005-06-27 2012-08-09 Solid preparation

Publications (3)

Publication Number Publication Date
JP2008543729A JP2008543729A (en) 2008-12-04
JP2008543729A5 true JP2008543729A5 (en) 2009-08-06
JP5110697B2 JP5110697B2 (en) 2012-12-26

Family

ID=37460221

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007558257A Active JP5110697B2 (en) 2005-06-27 2006-06-26 Solid preparation
JP2012177601A Active JP5456857B2 (en) 2005-06-27 2012-08-09 Solid preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012177601A Active JP5456857B2 (en) 2005-06-27 2012-08-09 Solid preparation

Country Status (3)

Country Link
JP (2) JP5110697B2 (en)
TW (1) TWI388345B (en)
WO (1) WO2007001067A2 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5940073A (en) 1996-05-03 1999-08-17 Starsight Telecast Inc. Method and system for displaying other information in a TV program guide
GT200600371A (en) * 2005-08-17 2007-03-21 SOLID DOSE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD TO DO THE SAME
US9113107B2 (en) 2005-11-08 2015-08-18 Rovi Guides, Inc. Interactive advertising and program promotion in an interactive television system
US20100237530A1 (en) * 2006-06-27 2010-09-23 Daiichi Sankyo Company, Limited Compressed preparation
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
US8832742B2 (en) 2006-10-06 2014-09-09 United Video Properties, Inc. Systems and methods for acquiring, categorizing and delivering media in interactive media guidance applications
KR101247583B1 (en) * 2006-12-08 2013-03-26 한미사이언스 주식회사 Pharmaceutical composition comprising amlodipine or a pharmaceutically acceptable salt thereof and losartan or a pharmaceutically acceptable salt thereof
TWI488658B (en) * 2006-12-26 2015-06-21 Daiichi Sankyo Co Ltd Method for improvement of elution
TWI402083B (en) * 2006-12-26 2013-07-21 Daiichi Sankyo Co Ltd Solid dosage form and stabilization method thereof
TWI414310B (en) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd Elution-improved pharmaceutical preparation
ES2817504T3 (en) * 2008-01-25 2021-04-07 Laboratoires Majorelle Oral Drug Combinations Bound by an Envelope
WO2009113420A1 (en) * 2008-03-13 2009-09-17 第一三共株式会社 Improvement of dissolvability of preparation containing olmesartan medoxomil
UY32126A (en) * 2008-09-25 2010-04-30 Takeda Pharmaceutical SOLID PHARMACEUTICAL COMPOSITION
NZ594738A (en) * 2009-01-23 2013-11-29 Hanmi Science Co Ltd Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
US9173848B2 (en) * 2009-06-30 2015-11-03 Sanofi Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
JP5886530B2 (en) * 2010-02-26 2016-03-16 第一三共株式会社 tablet
JP5421945B2 (en) * 2010-03-10 2014-02-19 大日本住友製薬株式会社 Pharmaceutical composition containing irbesartan and amlodipine or a salt thereof
JP5824222B2 (en) * 2010-03-31 2015-11-25 第一三共株式会社 Method for producing solid preparation
EP2632438A1 (en) * 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
UY33772A (en) * 2010-12-09 2012-07-31 Lg Life Sciences Ltd PHARMACEUTICAL COMPOSITION THAT INCLUDES LERCANIDIPINE CHLORHYDRATE AND VALSARTAN AS ACTIVE COMPONENTS AND TO A METHOD FOR THE PREPARATION OF THE SAME.
JP6041591B2 (en) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 Stabilized pharmaceutical composition comprising irbesartan and amlodipine or a salt thereof
KR20160128449A (en) * 2012-10-12 2016-11-07 이에이 파마 가부시키가이샤 Pharmaceutical preparation containing calcium antagonist/angiotensin ii receptor antagonist
MX2013001277A (en) * 2013-01-31 2014-07-30 Miguel Ángel García Pérez Pharmaceutical composition comprising an angiotensin ii-receptor antagonist and a calcium channel blocker for the treatment of arterial hypertension.
CN103127110A (en) * 2013-03-18 2013-06-05 吉林省博大伟业制药有限公司 Compound preparation containing angiotensin II receptor antagonist and calcium channel blocker
CN103271908B (en) * 2013-05-23 2019-02-12 浙江华海药业股份有限公司 Oral tablet and preparation method thereof containing Telmisartan and Amlodipine Besylate Tablet
ES2847904T3 (en) * 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicine for the prevention or treatment of hypertension
CN103908539B (en) * 2014-05-03 2017-02-01 李全浩 Traditional Chinese medicine composition for treating hypertension as well as preparation method and application of traditional Chinese medicine composition
CN104000821B (en) * 2014-06-02 2020-06-19 浙江华海药业股份有限公司 Oral double-layer tablet containing telmisartan and amlodipine besylate and preparation method thereof
EP3244880A1 (en) * 2015-01-12 2017-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi A stable bilayer pharmaceutical tablet compositions comprising fixed dose of irbesartan and amlodipine
CA3015964C (en) * 2016-03-24 2021-08-03 Daiichi Sankyo Company, Limited Medicine for treating renal disease
CN109432034A (en) * 2018-12-28 2019-03-08 乐普制药科技有限公司 A kind of valsartan amlodipine tri-layer tablets and preparation method thereof
CN110237073B (en) * 2019-07-10 2022-12-02 安庆回音必制药股份有限公司 Olmesartan medoxomil amlodipine tablet and preparation method thereof
CN114712319B (en) * 2022-03-25 2024-01-09 北京诺康达医药科技股份有限公司 Felodipine and propranolol hydrochloride compound preparation and preparation method thereof
CN115227662B (en) * 2022-06-24 2023-11-24 辰欣药业股份有限公司 Valsartan amlodipine tablet and preparation method thereof
CN115944600B (en) * 2022-12-01 2024-05-28 山东齐都药业有限公司 Oral tablet containing telmisartan and amlodipine besylate and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0859470A (en) * 1994-08-29 1996-03-05 Sankyo Co Ltd Elution improving preparation of cyclopenta(alpha)pyrimidine derivative
US6395728B2 (en) * 1999-07-08 2002-05-28 Novartis Ag Method of treatment and pharmaceutical composition
EP2260833B1 (en) * 2002-01-16 2012-11-21 Boehringer Ingelheim Pharma GmbH & Co. KG Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
JP3751287B2 (en) * 2002-03-27 2006-03-01 バイエル薬品株式会社 Miniaturized nifedipine nucleated tablets
AU2003227472A1 (en) * 2002-03-27 2003-10-08 Bayer Aktiengesellschaft Downsized core tablet containing nifedipine
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
JP2004300102A (en) * 2003-03-31 2004-10-28 Kissei Pharmaceut Co Ltd Condensed heterocyclic derivative, pharmaceutical composition containing the same and its pharmaceutical application
US20050187262A1 (en) * 2004-01-12 2005-08-25 Grogan Donna R. Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use
UA89065C2 (en) * 2004-11-05 2009-12-25 Бёрингэр Ингэльхайм Интэрнациональ Гмбх Bilayer tablet comprising telmisartan and amlodipine

Similar Documents

Publication Publication Date Title
JP2008543290A5 (en)
JP2008543728A5 (en)
JP2009511485A5 (en)
JP2008543729A5 (en)
JP2009507826A5 (en)
JP2008533230A5 (en)
JP2009543688A5 (en)
JP2009538387A5 (en)
JP2009506999A5 (en)
JP2009525726A5 (en)
JP2008543830A5 (en)
JP2009503140A5 (en)
JP2009542573A5 (en)
JP2007321035A5 (en)
JP2006257115A5 (en)
JP2008538930A5 (en)
JP2007231207A5 (en)
JP2009520703A5 (en)
JP2006045672A5 (en)
JP2006063441A5 (en)
JP2007246653A5 (en)
JP2007190226A5 (en)
JP2006273834A5 (en)
JP2007254440A5 (en)
JP2009512653A5 (en)